Last month, a multidisciplinary panel led by the Infectious Diseases Society of America, the American Academy of Neurology, and the American College of Rheumatology published the 2020 Guidelines for the Prevention, Diagnosis and Treatment of Lyme Disease in Clinical Infectious Diseases.

The authors say it provides recommendations aimed to serve as a meaningful resource for the safe, effective, evidence-based care of people with Lyme disease.

Here to give her views on the guidelines is attorney and the Chief Executive Officer of LymeDisease.org, Lorraine Johnson, JD, MBA.